CYP2C9 c.1078G>A ;(p.D360N)

Variant ID: 10-96741056-G-A

NM_000771.3(CYP2C9):c.1078G>A;(p.D360N)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data.

Npj Genomic Medicine
Lanillos, Javier J; Carcajona, Marta M; Maietta, Paolo P; Alvarez, Sara S; Rodriguez-Antona, Cristina C
Publication Date: 2022-02-18

Variant appearance in text: CYP2C9: 1078G>A; Asp360Asn; rs774992703
PubMed Link: 35181665
Variant Present in the following documents:
  • 41525_2022_283_MOESM4_ESM.xlsx, sheet 1
View BVdb publication page



CYP2C9 and CYP2C19: Deep Mutational Scanning and Functional Characterization of Genomic Missense Variants.

Clinical And Translational Science
Zhang, Lingxin L; Sarangi, Vivekananda V; Moon, Irene I; Yu, Jia J; Liu, Duan D; Devarajan, Sandhya S; Reid, Joel M JM; Kalari, Krishna R KR; Wang, Liewei L; Weinshilboum, Richard R
Publication Date: 2020-07

Variant appearance in text: CYP2C9: 1078G>A; D360N
PubMed Link: 32004414
Variant Present in the following documents:
  • CTS-13-727.pdf
View BVdb publication page



Assessing the capability of massively parallel sequencing for opportunistic pharmacogenetic screening.

Genetics In Medicine : Official Journal Of The American College Of Medical Genetics
Ng, David D; Hong, Celine S CS; Singh, Larry N LN; Johnston, Jennifer J JJ; Mullikin, James C JC; Biesecker, Leslie G LG
Publication Date: 2017-03

Variant appearance in text: CYP2C9: 1078G>A; Asp360Asn
PubMed Link: 27537706
Variant Present in the following documents:
  • NIHMS802548-supplement-Table_S4.pdf
View BVdb publication page



Influence of CYP2C9 Genotype on warfarin dose among African American and European Americans.

Personalized Medicine
Limdi, Na N; Goldstein, Ja J; Blaisdell, Ja J; Beasley, Tm T; Rivers, Ca C; Acton, Rt R
Publication Date: 2007-05-01

Variant appearance in text: CYP2C9: D360N
PubMed Link: 19802360
Variant Present in the following documents:
  • Main text
View BVdb publication page



A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy.

Blood Cells, Molecules & Diseases
Goldstein, J A JA; Blaisdell, J A JA; Limdi, N A NA
Publication Date: 2009

Variant appearance in text: CYP2C9: D360N
PubMed Link: 19083245
Variant Present in the following documents:
  • Main text
View BVdb publication page